The PKA phosphorylation of vitronectin: effect on conformation and function

Area of Science:

• Biochemistry
• Molecular Biology
• Hemostasis and Thrombosis

Background:

• Vitronectin (Vn) plays a crucial role in stabilizing the inhibitory form of plasminogen activator inhibitor-1 (PAI-1), a key regulator of fibrinolysis.
• Previous research identified specific phosphorylation of Vn by Protein Kinase A (PKA) at Serine 378 (Ser378), with PKA being released from activated platelets.

Purpose of the Study:

• To elucidate the molecular consequences of PKA-mediated Vn phosphorylation at Ser378.
• To investigate how this phosphorylation affects Vn conformation and its interactions with PAI-1 and plasminogen.
• To understand the implications of Vn phosphorylation in controlling fibrinolysis.

Main Methods:

• Circular dichroism spectroscopy to assess conformational changes in Vn.
• Site-directed mutagenesis (Ser378Ala, Ser378Glu) to confirm phosphorylation site specificity.
• In vitro phosphorylation assays with PKA, PAI-1, heparin, and Vn.
• Binding assays to evaluate the interaction of phosphorylated Vn with immobilized PAI-1 and plasminogen.

Main Results:

• PKA phosphorylation of Vn at Ser378 modulates its conformation, as indicated by circular dichroism.
• The presence of PAI-1 and/or heparin enhances PKA-mediated phosphorylation of Vn specifically at Ser378.
• Phosphorylation of Vn by PKA leads to reduced binding affinity to immobilized PAI-1 and plasminogen compared to unphosphorylated Vn.

Conclusions:

• PKA-mediated phosphorylation of Vitronectin at Ser378 is a significant post-translational modification with functional consequences.
• This phosphorylation event alters Vn conformation, impacting its interactions with key proteins in the fibrinolytic system.
• The findings suggest a novel mechanism by which platelet activation can modulate fibrinolysis through Vitronectin phosphorylation.